Gender difference in the response to valsartan/amlodipine single-pill combination in essential hypertension (China Status II): An observational study

BACKGROUND: The China STATUS II is a prospective, multicentre, open-label, post-marketing, observational study including Chinese adults (aged ⩾ 18 years) with essential hypertension who were prescribed once-daily valsartan/amlodipine (Val/Aml 80/5 mg) single-pill combination. In order to examine gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huan, Chen, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843875/
https://www.ncbi.nlm.nih.gov/pubmed/27127102
http://dx.doi.org/10.1177/1470320316643903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843875/
https://www.ncbi.nlm.nih.gov/pubmed/27127102
http://dx.doi.org/10.1177/1470320316643903

Ejemplares similares